Ronald Asbury Andrews Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ronald Asbury Andrews.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ronald Asbury Andrews. Ronald Asbury Andrews is President & CEO in CLARIENT, INC ($CVSN) and President and CEO in CLARIENT, INC ($CVSN) and Director in Precipio, Inc. ($PRPO) and Director in Oxford Immunotec Global PLC ($OXFD) and CEO and President in OncoCyte Corp ($OCX) and Chief Executive Officer in OncoCyte Corp ($OCX) and Director in OncoCyte Corp ($OCX).
Latest Insider Trading Transactions of Ronald Asbury Andrews
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CVSN, OCX, OXFD, PRPO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22 2021 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Chief Executive Off ... | Buy | P | 4.79 | 11,000 | 52,702 | 113,698 | 102.7 K to 113.7 K (+10.71 %) |
| Mar 04 2021 | PRPO | Precipio, Inc. | ANDREWS RONALD ASBURY | Director | Option Exercise | A | 2.60 | 5,171 | 13,445 | 5 | |
| Mar 04 2021 | PRPO | Precipio, Inc. | ANDREWS RONALD ASBURY | Director | Option Exercise | A | 2.60 | 2,069 | 5,379 | 2,069 | |
| Aug 04 2020 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Chief Executive Off ... | Buy | P | 1.35 | 40,000 | 53,880 | 102,698 | 62.7 K to 102.7 K (+63.80 %) |
| Jun 26 2020 | OXFD | Oxford Immunotec G ... | ANDREWS RONALD ASBURY | Director | Option Exercise | A | 12.96 | 9,494 | 123,042 | 9,494 | |
| Jun 26 2020 | OXFD | Oxford Immunotec G ... | ANDREWS RONALD ASBURY | Director | Grant | A | 0.00 | 4,081 | 0 | 4,081 | 0 to 4.1 K |
| May 12 2020 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Chief Executive Off ... | Option Exercise | A | 0.00 | 106,221 | 0 | 106,221 | |
| Apr 01 2020 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | CEO and President | Buy | P | 2,372.00 | 18,000 | 42,696,000 | 62,698 | 44.7 K to 62.7 K (+40.27 %) |
| Apr 01 2020 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | CEO and President | Buy | P | 2.26 | 27,216 | 61,454 | 44,698 | 17.5 K to 44.7 K (+155.68 %) |
| Jul 03 2019 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Chief Executive Off ... | Option Exercise | A | 2.51 | 950,000 | 2,384,500 | 950,000 | |
| Jun 19 2019 | OXFD | Oxford Immunotec G ... | ANDREWS RONALD ASBURY | Director | Option Exercise | A | 14.44 | 7,457 | 107,679 | 7,457 | |
| Sep 04 2018 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Director | Option Exercise | A | 2.40 | 45,000 | 108,000 | 45,000 | |
| Jul 31 2018 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Director | Option Exercise | P | 3.00 | 17,482 | 52,446 | 17,482 | |
| Jul 31 2018 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Director | Buy | P | 0.00 | 17,482 | 0 | 17,482 | 0 to 17.5 K |
| Jul 31 2018 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Director | Option Exercise | P | 3.00 | 17,482 | 52,446 | 17,482 | |
| Jul 31 2018 | OCX | OncoCyte Corp | ANDREWS RONALD ASBURY | Director | Buy | P | 0.00 | 17,482 | 0 | 17,482 | 0 to 17.5 K |
| Jun 21 2018 | OXFD | Oxford Immunotec G ... | ANDREWS RONALD ASBURY | Director | Option Exercise | A | 14.49 | 7,457 | 108,052 | 7,457 | |
| Jun 08 2017 | OXFD | Oxford Immunotec G ... | ANDREWS RONALD ASBURY | Director | Option Exercise | A | 14.46 | 7,457 | 107,828 | 7,457 | |
| Jun 29 2016 | OXFD | Oxford Immunotec G ... | ANDREWS RONALD ASBURY | Director | Option Exercise | A | 8.65 | 7,457 | 64,503 | 7,457 | |
| Nov 06 2015 | OXFD | Oxford Immunotec G ... | ANDREWS RONALD ASBURY | Director | Option Exercise | A | 12.50 | 14,914 | 186,425 | 14,914 | |
| Nov 06 2015 | OXFD | Oxford Immunotec G ... | ANDREWS RONALD ASBURY | Director | Option Exercise | A | 12.50 | 7,457 | 93,213 | 7,457 | |
| Apr 05 2006 | CVSN | CLARIENT, INC | Andrews Ronald Asbury | President and CEO | Option Exercise | A | 1.12 | 200,000 | 224,000 | 200,000 | |
| Nov 16 2005 | CVSN | CLARIENT, INC | Andrews Ronald Asbury | President and CEO | Buy | P | 1.19 | 10,000 | 11,880 | 48,000 | 38 K to 48 K (+26.32 %) |
| Jun 16 2005 | CVSN | CLARIENT, INC | Andrews Ronald Asbury | President and CEO | Buy | P | 1.40 | 18,000 | 25,250 | 38,000 | 20 K to 38 K (+90.00 %) |
| Nov 30 2004 | CVSN | CLARIENT, INC | Andrews Ronald Asbury | President and CEO | Option Exercise | A | 1.15 | 100,000 | 115,000 | 100,000 | |
| Aug 10 2004 | CVSN | CLARIENT, INC | Andrews Ronald Asbury | President & CEO | Buy | P | 1.15 | 20,000 | 23,000 | 20,000 | 0 to 20 K |
Page: 1